Standout Papers
Citation Impact
Citing Papers
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults
2007
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia
2018 Standout
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
The effect of COVID certificates on vaccine uptake, health outcomes, and the economy
2022 StandoutNobel
A Population-Based Study of the Effectiveness of Inferior Vena Cava Filter Use Among Patients With Venous Thromboembolism
2000
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Pulmonary Embolism
1998
Incidence and clinical significance of anti‐PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin‐induced thrombocytopenia
2006
Isolated calf deep vein thrombosis in the community setting: the Worcester Venous Thromboembolism study
2012
Günther Tulip Retrievable Vena Cava Filter: Results from the Registry of the Canadian Interventional Radiology Association
2001
The inter-rater reliability of the Pulmonary Embolism Severity Index
2010
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Silent Pulmonary Embolism in Patients with Deep Venous Thrombosis: A Systematic Review
2010
Ambulatory management of pulmonary embolism: a pragmatic evaluation
2010
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
1998 Standout
Cerebral venous thrombosis: an update
2007 Standout
Six-Month Echocardiographic Study in Patients With Submassive Pulmonary Embolism and Right Ventricle Dysfunction: Comparison of Thrombolysis With Heparin
2010
Deep venous thrombosis after percutaneous insertion of vena caval filters
1999
Evidence-Based Management of Anticoagulant Therapy
2012
Long-Term Follow-Up of Trauma Patients with a Vena Caval Filter
2000
Postthrombotic Syndrome in Relation to Vena Cava Filter Placement: A Systematic Review
2008
Laboratory Testing for Heparin-Induced Thrombocytopenia
2000
Increased use of prophylactic vena cava filters in trauma patients failed to decrease overall incidence of pulmonary embolism
1999
Prevention of venous thromboembolism
2001
Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients
2004
Prophylactic and Therapeutic Inferior Vena Cava Filters to Prevent Pulmonary Emboli in Trauma Patients
2002
Extended outpatient therapy with low molecular weight heparin for the treatment of recurrent venous thromboembolism despite warfarin therapy
2001
Reporting Standards for Endovascular Treatment of Lower Extremity Deep Vein Thrombosis
2006
Antithrombotic Therapy for VTE Disease
2016 Standout
The role of vena caval filters in the management of venous thromboembolism
2004
Update on Inferior Vena Cava Filters
2003
Prognostic Value of ECG Among Patients with Acute Pulmonary Embolism and Normal Blood Pressure
2009
Clinical Recognition of Pulmonary Embolism: Problem of Unrecognized and Asymptomatic Cases
1998
The 6-F Nitinol TrapEase Inferior Vena Cava Filter: Results of a Prospective Multicenter Trial
2001
Unresolved issues in anticoagulant therapy
2003
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2008 Standout
Antiphospholipid Syndrome and Heparin-induced Thrombocytopenia: Update on Similarities and Differences
2000
Attitudes, acceptance and hesitancy among the general population worldwide to receive the COVID-19 vaccines and their contributing factors: A systematic review
2021
Temporal Aspects of Heparin-Induced Thrombocytopenia
2001 Standout
Deep-vein thrombosis
1999
Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians
2017 Standout
Are temporary inferior vena cava filters really temporary?
2005
The percutaneous Greenfield filter: Outcomes and practice patterns
2000
Treatment of Deep-Vein Thrombosis
2004
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
2001 StandoutNature
Duplex scan–directed placement of inferior vena cava filters: A five-year institutional experience
2002
Enoxaparin for thromboprophylaxis after major trauma: Potential cost implications
2001
Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia
1999
Twenty-one-Year Trends in the Use of Inferior Vena Cava Filters
2004
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism
2004 Standout
Deep Venous Thrombosis
2004
Platelet Activation and Atherothrombosis
2007 Standout
Travel and venous thrombosis
2002
Fondaparinux for the Treatment of Superficial-Vein Thrombosis in the Legs
2010
The Role of Temporary Inferior Vena Cava Filters in Critically Ill Surgical Patients
2003
Heparin-Induced Thrombocytopenia
2006 Standout
The Antiphospholipid Syndrome
2002 Standout
Thrombotic Thrombocytopenic Purpura Associated with Clopidogrel
2000
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
On the Dependency of Cellular Protein Levels on mRNA Abundance
2016 Standout
Impact of Vena Cava Filters on In-hospital Case Fatality Rate from Pulmonary Embolism
2012
Medical management of patients with brain tumors
2006
Prophylactic vena cava filters for trauma patients: a systematic review of the literature
2003
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Malignant Gliomas in Adults
2008 Standout
Endovascular Therapy for Acute Pulmonary Embolism
2011
Medical literature, vena cava filters and evidence of efficacy
2013
Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
2008 Standout
Prevention of Venous Thromboembolism
2004 Standout
Heparin and Low-Molecular-Weight Heparin
1998
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
A prospective observational study of IVC filters in pediatric patients
2008
Medical Literature and Vena Cava Filters
2002
Major Pulmonary Embolism
2002
The Inferior Vena Cava Filter
2013
Guidelines for the Use of Retrievable and Convertible Vena Cava Filters: Report from the Society of Interventional Radiology Multidisciplinary Consensus Conference
2006
Pulmonary thromboembolic disease spectrum: diagnostic and therapeutic strategies
2009
Retrievable Vena Cava Filters for Preventing Pulmonary Embolism in Trauma Patients: A Cautionary Tale
2006
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Vena Cava Filter Occlusion and Venous Thromboembolism Risk in Persistently Anticoagulated Patients
2009
Prevention of Venous Thromboembolism
2008 Standout
Development of a Research Agenda for Inferior Vena Cava Filters: Proceedings from a Multidisciplinary Research Consensus Panel
2009
Outcomes and Cost of Deep Venous Thrombosis Among Patients With Cancer
2004
Mechanical thrombectomy in patients with deep venous thrombosis
2001
Validation of a clinical algorithm to identify low‐risk patients with pulmonary embolism
2010
The pathophysiology and management of thrombotic thrombocytopenic purpura
1996
Role of fibrin D-dimer testing in emergency medicine
2003
A Prospective Long-term Study of 220 Patients With a Retrievable Vena Cava Filter for Secondary Prevention of Venous Thromboembolism
2007
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
2008
Modern surgical treatment of massive pulmonary embolism: Results in 47 consecutive patients after rapid diagnosis and aggressive surgical approach
2005
Use of Retrievable Compared to Permanent Inferior Vena Cava Filters: A Single-Institution Experience
2007
Deep vein thrombosis
2005
Survival Effects of Inferior Vena Cava Filter in Patients With Acute Symptomatic Venous Thromboembolism and a Significant Bleeding Risk
2014
Recommended Reporting Standards for Vena Caval Filter Placement and Patient Follow-Up
1999
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
1999 Standout
Hemorrhagic Complications of Anticoagulant Treatment
2001 Standout
Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysis
2004 Standout
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
2010 Standout
Prevention of Venous Thromboembolism
1998
Hemorrhagic Complications of Anticoagulant Treatment
2004
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
2013 Standout
Prospective randomized study comparing the clinical outcomes between inferior vena cava Greenfield and TrapEase filters
2010
Antithrombotic Therapy for Venous Thromboembolic Disease
2004 Standout
Identification of the platelet ADP receptor targeted by antithrombotic drugs
2001 StandoutNatureNobel
Thrombosis of the Cerebral Veins and Sinuses
2005 Standout
In-Vivo Quantitative Proteomics Reveals a Key Contribution of Post-Transcriptional Mechanisms to the Circadian Regulation of Liver Metabolism
2014
Deep Venous Thrombosis Associated with Corporate Air Travel
2006
Heparin-induced multiple electrode aggregometry is a promising and useful functional tool for heparin-induced thrombocytopenia diagnosis: Confirmation in a prospective study
2012
Clinical Risk Factors and Timing of Recurrent Venous Thromboembolism During the Initial 3 Months of Anticoagulant Therapy
2000
Venous Thromboembolism
1999
Impact of the patient population on the risk for heparin-induced thrombocytopenia
2000 Standout
Deep-vein thrombosis in high-energy skeletal trauma despite thromboprophylaxis
2005
Treatment for superficial thrombophlebitis of the leg
2013
Fibrinolysis for acute pulmonary embolism
2010
College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy.
1998
Do Heparins Do More than Just Treat Thrombosis? The Influence of Heparins on Cancer Spread
1999
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
2017 Standout
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
2002 Standout
Vena caval filters: a comprehensive review
2000
Endovascular Treatment for Iliac Vein Compression Syndrome: a Comparison between the Presence and Absence of Secondary Thrombosis
2009
A Negative D-Dimer Assay Does Not Rule Out Cerebral Venous Thrombosis
2005
Heparin-induced Thrombocytopenia: Towards Consensus
1998
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
2010 Standout
Fondaparinux or Enoxaparin for the Initial Treatment of Symptomatic Deep Venous Thrombosis
2004
Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation
2001 Standout
Management of Pulmonary Embolism with Rheolytic Thrombectomy
2011
FcγRIIA H/R131 Polymorphism, Subclass-Specific IgG Anti-Heparin/Platelet Factor 4 Antibodies and Clinical Course in Patients With Heparin-Induced Thrombocytopenia and Thrombosis
1997
Natural History of Venous Thromboembolism
2003
Cerebral venous thrombosis: Update on clinical manifestations, diagnosis and management
2008
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Epidemiology of cancer-associated venous thrombosis
2013
Do Normal D-dimer Levels Reliably Exclude Cerebral Sinus Thrombosis?
2004
Hyperglycemic Crises in Adult Patients With Diabetes
2009 Standout
The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme. Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease
2000
The Role of Surveillance Duplex Scanning in Preventing Venous Thromboembolism in Trauma Patients
2002
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
Antibody Inhibitors to von Willebrand Factor Metalloproteinase and Increased Binding of von Willebrand Factor to Platelets in Ticlopidine-Associated Thrombotic Thrombocytopenic Purpura
2000
Low-Molecular-Weight Heparin Compared with Intravenous Unfractionated Heparin for Treatment of Pulmonary Embolism
2004
Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis.
2003
Systematic Review: d -Dimer to Predict Recurrent Disease after Stopping Anticoagulant Therapy for Unprovoked Venous Thromboembolism
2008
Clinical Predictors for Fatal Pulmonary Embolism in 15 520 Patients With Venous Thromboembolism
2008
Superficial Venous Thrombosis and Venous Thromboembolism
2010
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
First Workshop for Detection of Heparin-induced Antibodies: Validation of the Heparin-induced Platelet-activation Test (HIPA) in Comparison with a PF4/Heparin ELISA
1999
Massive Pulmonary Embolism
2006
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
2021 Standout
Practice Guidelines for the Management of Bacterial Meningitis
2004 Standout
Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic itinerary, resulting in retention of low-density lipoprotein on the cell surface
2002 StandoutNobel
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism
2004
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
2021 Standout
Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis
2005 Standout
Is measurement of d -dimer useful in the diagnosis of cerebral venous thrombosis?
2003
Systematic Review: Case-Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding Events Among Patients Treated for Venous Thromboembolism
2010
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
2021 Standout
Works of Bernard Tardy being referenced
Risk factors for unfavorable clinical outcome in patients with documented heparin-induced thrombocytopenia
2009
Efficacy and Safety of Danaparoid Sodium (ORG 10172) in Critically Ill Patients With Heparin-Associated Thrombocytopenia
1999
Superficial vein thrombosis: risk factors, diagnosis, and treatment
2003
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
1998 Standout
Serum and ascitic procalcitonin levels in cirrhotic patients with spontaneous bacterial peritonitis: diagnostic value and relationship to pro-inflammatory cytokines
2000
Circadian Dynamics of Coagulation and Chronopathology of Cardiovascular and Cerebrovascular Events
1991
Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic
2020
Evolution of blood coagulation and fibrinolysis parameters after abrupt versus gradual withdrawal of acenocoumarol in patients with venous thromboembolism: a double‐blind randomized study
1997
Does bicarbonate therapy improve the management of severe diabetic ketoacidosis?
1999
Thrombotic thrombocytopenic purpura related to ticlopidine
1991
Intention to get vaccinations against COVID-19 in French healthcare workers during the first pandemic wave: a cross-sectional survey
2020
Pentosan polysulfate‐induced thrombocytopenia and thrombosis
1994
D-dimer levels in patients with suspected acute cerebral venous thrombosis
2002
Absence of cross-reactivity of SR90107A/ORG31540 pentasaccharide with antibodies to heparin-PF4 complexes developed in heparin-induced thrombocytopenia
1997
Short term effect of recombinant tissue plasminogen activator in patients with hemodynamically stable acute pulmonary embolism: Results of a meta-analysis involving 464 patients
2009
Annual diagnosis rate of superficial vein thrombosis of the lower limbs: the STEPH community‐based study
2014
Symptomatic inferior vena cava filter thrombosis: clinical study of 30 consecutive cases
1996
Early versus Delayed Introduction of Oral Vitamin K Antagonists in Combination with Low-Molecular-Weight Heparin in the Treatment of Deep Vein Thrombosis
1998
High Sensitivity and Specificity of Serum Procalcitonin Levels in Adults with Bacterial Meningitis
1999
Diagnosis of Pulmonary Embolism in Patients with Proximal Deep Vein Thrombosis
2001
Prognostic Factors for Pulmonary Embolism
2009
[Phlebitis following travel].
1993
Value of TENS for relief of chronic low back pain with or without radicular pain
2011
Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia
1996
Evaluation of D-dimer ELISA Test in Elderly Patients with Suspected Pulmonary Embolism
1998
Acute Psychiatric Syndrome Leading Young Patients to ICU: Consider Anti-NMDA-Receptor Antibodies.
2010
Inferior Vena Cava Interruption: How and When?
2000